Ulivi P - Search Results

1

Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.

Ulivi P, Scarpi E, Chiadini E, Marisi G, Valgiusti M, Capelli L, Casadei Gardini A, Monti M, Ruscelli S, Frassineti GL, Calistri D, Amadori D, Passardi A. Ulivi P, et al. Int J Mol Sci. 2017 Jun 9;18(6):1240. doi: 10.3390/ijms18061240. Int J Mol Sci. 2017. PMID: 28598398 Free PMC article.

2

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

Ricotti L, Tesei A, De Paola F, Ulivi P, Frassineti GL, Milandri C, Amadori D, Zoli W. Ricotti L, et al. Among authors: ulivi p. Clin Cancer Res. 2003 Feb;9(2):900-5. Clin Cancer Res. 2003. PMID: 12576465

3

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: ulivi p. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

4

Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells.

Ricotti L, Tesei A, De Paola F, Milandri C, Amadori D, Frassineti GL, Ulivi P, Zoli W. Ricotti L, et al. Among authors: ulivi p. J Chemother. 2003 Oct;15(5):480-7. doi: 10.1179/joc.2003.15.5.480. J Chemother. 2003. PMID: 14598941

5

Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.

Zoli W, Ricotti L, Tesei A, Ulivi P, Gasperi Campani A, Fabbri F, Gunelli R, Frassineti GL, Amadori D. Zoli W, et al. Among authors: ulivi p. Clin Cancer Res. 2004 Feb 15;10(4):1500-7. doi: 10.1158/1078-0432.ccr-1107-03. Clin Cancer Res. 2004. PMID: 14977854

6

c-kit and SCF expression in normal and tumor breast tissue.

Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R. Ulivi P, et al. Breast Cancer Res Treat. 2004 Jan;83(1):33-42. doi: 10.1023/B:BREA.0000010694.35023.9e. Breast Cancer Res Treat. 2004. PMID: 14997053

7

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.

Fabbri F, Brigliadori G, Ulivi P, Tesei A, Vannini I, Rosetti M, Bravaccini S, Amadori D, Bolla M, Zoli W. Fabbri F, et al. Among authors: ulivi p. Apoptosis. 2005 Oct;10(5):1095-103. doi: 10.1007/s10495-005-0619-7. Apoptosis. 2005. PMID: 16151642

8

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

Ulivi P, Zoli W, Calistri D, Fabbri F, Tesei A, Rosetti M, Mengozzi M, Amadori D. Ulivi P, et al. J Cell Physiol. 2006 Mar;206(3):611-5. doi: 10.1002/jcp.20503. J Cell Physiol. 2006. PMID: 16222700

9

Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.

Leonetti C, Scarsella M, Zupi G, Zoli W, Amadori D, Medri L, Fabbri F, Rosetti M, Ulivi P, Cecconetto L, Bolla M, Tesei A. Leonetti C, et al. Among authors: ulivi p. Mol Cancer Ther. 2006 Apr;5(4):919-26. doi: 10.1158/1535-7163.MCT-05-0536. Mol Cancer Ther. 2006. PMID: 16648562

10

Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.

Rosetti M, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Amadori D, Bolla M, Zoli W. Rosetti M, et al. Among authors: ulivi p. Apoptosis. 2006 Aug;11(8):1321-30. doi: 10.1007/s10495-006-6986-x. Apoptosis. 2006. PMID: 16699954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters